344 related articles for article (PubMed ID: 31452347)
1. Diffuse large B-cell lymphoma in a patient with dermatomyositis-associated interstitial lung disease: A case report.
Li S; Sun Y; Shao C; Xu K; Huang H
Thorac Cancer; 2019 Oct; 10(10):2035-2039. PubMed ID: 31452347
[TBL] [Abstract][Full Text] [Related]
2. Progressive dyspnea and diffuse ground-glass opacities after treatment for lymphoma with rituximab-containing chemotherapy: A case report.
Sun Y; Shao C; Xu K; Li J; Zhang Y; Liu P; Huang H; Feng R
Thorac Cancer; 2020 Jul; 11(7):2040-2043. PubMed ID: 32374517
[TBL] [Abstract][Full Text] [Related]
3. A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Binkley MS; Hiniker SM; Wu S; Natkunam Y; Mittra ES; Advani RH; Hoppe RT
Leuk Lymphoma; 2016; 57(3):604-8. PubMed ID: 26159046
[TBL] [Abstract][Full Text] [Related]
4. Diffuse large B-cell lymphoma of the lung in a patient with nonspecific interstitial pneumonia.
Gorospe Sarasúa L; Arrieta P; Chinea-Rodríguez A; de la Puente-Bujidos C
Reumatol Clin (Engl Ed); 2019; 15(6):e151-e152. PubMed ID: 28867466
[No Abstract] [Full Text] [Related]
5. Histological improvement in salivary gland along with effector memory Th17-1 cell reduction in a primary Sjogren's syndrome patient with dermatomyositis and diffuse large B-cell lymphoma by R-CHOP therapy.
Koga T; Mizokami A; Nakashima M; Shimizu T; Nakashima Y; Nakamura H; Chiwata M; Daisuke N; Kawakami A
Clin Immunol; 2016 Apr; 165():35-7. PubMed ID: 26960952
[TBL] [Abstract][Full Text] [Related]
6. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Malkan UY; Albayrak M; Yildiz A; Maral S; Afacan Ozturk HB; Comert P
J Oncol Pharm Pract; 2021 Jan; 27(1):250-252. PubMed ID: 32507098
[TBL] [Abstract][Full Text] [Related]
7. A Rare Case of Diffuse Large B Cell Lymphoma Presenting as a Cardiac Mass.
Yousif P; Kotecha A; Thakur A; Ismail HM
Am J Case Rep; 2019 Dec; 20():1821-1825. PubMed ID: 31809493
[TBL] [Abstract][Full Text] [Related]
8. Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07).
Mamot C; Klingbiel D; Hitz F; Renner C; Pabst T; Driessen C; Mey U; Pless M; Bargetzi M; Krasniqi F; Gigli F; Hany T; Samarin A; Biaggi C; Rusterholz C; Dirnhofer S; Zucca E; Martinelli G
J Clin Oncol; 2015 Aug; 33(23):2523-9. PubMed ID: 26150440
[TBL] [Abstract][Full Text] [Related]
9. Rituximab-induced interstitial lung disease.
Wagner SA; Mehta AC; Laber DA
Am J Hematol; 2007 Oct; 82(10):916-9. PubMed ID: 17597477
[TBL] [Abstract][Full Text] [Related]
10. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
11. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
12. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
13. Respiratory symptoms as initial manifestations of interstitial lung disease in clinically amyopathic juvenile dermatomyositis: a case report with literature review.
Xia J; Jiang G; Jin T; Shen Q; Ma Y; Wang L; Qian L
BMC Pediatr; 2021 Nov; 21(1):488. PubMed ID: 34732158
[TBL] [Abstract][Full Text] [Related]
14. Primary pulmonary diffuse large B-cell lymphoma with multiple ground-glass nodules as the primary manifestation: A case report.
Wang Q; Yan H; Wang R; Li C; Li W; Xu Y; Su Z; Zhang J
Medicine (Baltimore); 2020 Dec; 99(50):e23501. PubMed ID: 33327289
[TBL] [Abstract][Full Text] [Related]
15. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
17. Severe Pancytopenia After COVID-19 Revealing a Case of Primary Bone Marrow Diffuse Large B Cell Lymphoma.
Kilani Y; Sohail H; Lim CY; Payette A; Kamal SAF; Afzal A; Khan T; Paracha N; Muppidi MR; Sittler D
Am J Case Rep; 2022 Sep; 23():e937500. PubMed ID: 36151707
[TBL] [Abstract][Full Text] [Related]
18. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
Alqatari S; Riddell P; Harney S; Henry M; Murphy G
BMC Pulm Med; 2018 Apr; 18(1):59. PubMed ID: 29665800
[TBL] [Abstract][Full Text] [Related]
19. Hypomyopathic dermatomyositis associated with interstitial lung disease and good response to mycophenolate mofetil: case-based review.
Koyama RVL; Braga TKK; da Silva Dias GA; Fujihara S; Fuzii HT; Yoshikawa GT
Clin Rheumatol; 2017 Aug; 36(8):1919-1926. PubMed ID: 28488124
[TBL] [Abstract][Full Text] [Related]
20. Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Hertzberg M; Gandhi MK; Trotman J; Butcher B; Taper J; Johnston A; Gill D; Ho SJ; Cull G; Fay K; Chong G; Grigg A; Lewis ID; Milliken S; Renwick W; Hahn U; Filshie R; Kannourakis G; Watson AM; Warburton P; Wirth A; Seymour JF; Hofman MS; Hicks RJ;
Haematologica; 2017 Feb; 102(2):356-363. PubMed ID: 28143954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
